ZIPHIUS
Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
ZIPHIUS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Merelbeke, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.ziphius.org
Total Employee:
11+
Status:
Active
Total Funding:
29.3 M EUR
Technology used in webpage:
Combell
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Biotherapy Services
Biotherapy Services is a biopharmaceutical company specialising in regenerative medicine for the treatment of complex wounds.
Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Oxford Cannabinoid Technologies
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Quercis Pharma
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Annie Vereecken
Annie Vereecken investment in Series A - Ziphius
Official Site Inspections
http://www.ziphius.org Semrush global rank: 4.73 M Semrush visits lastest month: 1.95 K
- Host name: linweb055.webhosting.be
- IP address: 176.62.169.31
- Location: Ghent Belgium
- Latitude: 51.147
- Longitude: 3.8212
- Timezone: Europe/Brussels
- Postal: 9042
More informations about "Ziphius"
Home | Ziphius
The in-house developed LNP library at Ziphius is specifically designed for saRNA delivery and ensures proper encapsulation, stability, and biodegradability of the LNP-saRNA complex. Furthermore, Ziphius is also focused on making LNPs …See details»
About us - Ziphius
Ziphius is a biopharmaceutical company, dedicated to develop saRNA vaccines and therapeutics. Ziphius focuses on both vaccines for infectious diseases and gene supplementation therapies …See details»
Pipeline - Ziphius
Ziphius NV (Headquarters) - Rijvisschestraat 120, 9052 Zwijnaarde, BELGIUM Ziphius (US Office) - 101 6th Ave 3rd floor, New York, NY 10013, USA [email protected] - www.ziphius.orgSee details»
Ziphius - Crunchbase Company Profile & Funding
Organization. Ziphius . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Ziphius - BIO International Convention 2024
Jun 4, 2024 Ziphius Add to Calendar. Tuesday, June 04, 2024 2:00 PM - 2:15 PM Company Presentation. Immunology Company Presentation Theater 1 Ziphius is a biotechnology …See details»
Ziphius Company Profile 2024: Valuation, Funding & Investors
Ziphius General Information Description. Developer of a global biopharmaceutical platform designed to offer vaccines for the prevention of infectious diseases. The company's platform …See details»
Ziphius - Crunchbase
Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Ziphius | flanders.bio
Oct 7, 2020 Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class …See details»
Ziphius Vaccines NV - BioWin
Mar 25, 2021 Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class of vaccines, the messenger RNA or …See details»
Our Technology - Ziphius
Ziphius is developing proprietary self-amplifying mRNA technologies combined with innovative lipid formulations for targeted delivery. This allows us to generate a broad pipeline of late pre-clinical and early clinical stage products, including …See details»
Ziphius Therapeutics - VentureRadar
Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class of vaccines, …See details»
Ziphius - LinkedIn
Ziphius is proud to introduce two new team members: Katleen Van Steendam joins us as Head of CMC. She has a Ph.D. in Pharmaceutical Sciences from the University of Ghent and brings …See details»
Ziphius - BIO Investor Forum 2024 - bif.bio.org
Oct 15, 2024 Ziphius is a preclinical biotech company specializing in vaccines and therapeutic drugs for infectious diseases, protein replacement therapies, and oncology. Founded in 2019, …See details»
NEXT STEPS TOWARDS ZIPHIUS CMP Issue: Conservation …
• Social organization • Information gaps/needs 3.2 HABITAT AND ECOLOGY • Distribution and movements (Key habitats, Diving behavior, Individual movements) Boldrocchi, Conte, Galli, …See details»
Ziphius Vaccines strengthens Leadership Team and provides …
Jan 11, 2021 Finally, Ziphius Vaccines will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021. If you would like to meet the management team, please …See details»
Ziphius | EU-Startups
Ziphius. Category. Belgium. Business Description. Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious …See details»
ZIP 1642 - AdisInsight - Springer
Dec 24, 2022 ZIP 1642 is a self-amplifying mRNA (saRNA) vaccine, being being developed by Ziphius Vaccines for the prevention of COVID-2019 infections. The vaccine encodes ZIP 1642 …See details»
Press releases | Ziphius
Ziphius NV (Headquarters) - Rijvisschestraat 120, 9052 Zwijnaarde, BELGIUM Ziphius (US Office) - 101 6th Ave 3rd floor, New York, NY 10013, USA [email protected] - www.ziphius.orgSee details»
Ziphius - Second Wiki
Ziphius is a genus of odontocetic cetaceans of the Ziphidae family of which 21 species are known, being the Cuvier's beaked whale (Ziphius cavirostris) the most common. References. …See details»
Ziphius Vaccines Accelerates its Promising sa-RNA Program with …
Sep 21, 2021 [email protected] September 21, 2021 at 12:00 PM CET Ziphius Vaccines (the “Company” or “Ziphius”), a self-amplifying RNA (saRNA) company developing …See details»